โ€• Advertisement โ€•

Tesla’s Global Sales Drop Masks a Hidden Victory in China

For the first time in over a decade, Tesla experienced a year-over-year decline in global vehicle deliveries. In 2024, Tesla delivered 1,789,226 electric vehicles...

A new sales king in town?

HomeWatcheswhy you will have to wait longer than expected

why you will have to wait longer than expected

Apple and Samsung are set to revolutionize the smartwatch world with a new feature: noninvasive blood sugar monitoring. But the FDA is warning against making premature promises. Find out why this long-awaited innovation could take longer than expected and what it means for smartwatch users.

FDA sounds alarm

The U.S. Food and Drug Administration (FDA) recently made an important statement:

  • No smartwatch or ring is currently authorized to measure blood sugar.
  • FDA warns against purchasing devices claiming to offer this feature
  • This warning comes even before the official launch of such products by major brands.
  • The challenge of non-invasive blood glucose measurement

    Currently, measuring blood sugar requires an invasive method:

  • An injection to obtain a drop of blood
  • Analysis of this sample by a medical device
  • Miniaturizing this technology to integrate it into a smartwatch poses many technical challenges.

    The race for innovation between Apple and Samsung

    The two tech giants are actively working on this technology:

  • Samsung announced in 2020 a non-invasive method developed with MIT
  • Apple is reportedly considering integrating this feature into its next Apple Watch
  • However, neither company has yet obtained FDA approval for this technology.

    The risks of premature marketing

    FDA Concerned About Potentially Misleading Marketing Claims:

  • Some brands may announce this feature before its official approval
  • Consumers at risk of being misled by unfulfilled promises
  • FDA recommends routinely checking device certification before purchase
  • The importance of official certification

    To ensure the reliability and security of this feature, several steps are necessary:

  • Rigorous clinical testing
  • A thorough evaluation by the FDA
  • Official certification before any marketing
  • What this means for smartwatch users

    While the prospect of noninvasive blood glucose monitoring is exciting, users should remain cautious:

  • Do not trust premature announcements from brands
  • Wait for official FDA certification before investing
  • Continue to use traditional methods of blood sugar monitoring in the meantime
  • Noninvasive blood glucose monitoring on smartwatches represents a potential technological breakthrough. However, the FDA's warning underscores the importance of scientific rigor and official certification before any commercialization.

    While Apple and Samsung are well positioned to deliver this innovation, users will likely have to wait longer than expected before they can enjoy this feature on their smartwatches.

    In the meantime, itโ€™s crucial to remain vigilant about marketing claims and always favor certified medical devices for blood glucose monitoring. The future of smartwatches as health tools is bright, but safety and reliability must remain top priorities.

    SRQ Backlot